Adaptive Biotechnologies Corporation (ADPT) has a market capitalization of $2.24B and trades at $14.53. The 52-week range is 6.706-20.76.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -37.3, Earnings Per Share (EPS) of $-0.39, annual revenue of $276.98M.
The stock has a beta of 2.30, operates in the Healthcare sector.
